Insider Selling: Electromed (NYSE:ELMD) Director Sells $1,419,200.00 in Stock

Posted by Brenda Bartman on May 22nd, 2026

Electromed, Inc. (NYSE:ELMD – Get Free Report) Director Kathleen Skarvan sold 40,000 shares of the business’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $35.48, for a total value of $1,419,200.00. Following the completion of the transaction, the director directly owned 35,622 shares in the company, valued at $1,263,868.56. This represents a 52.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Electromed Price Performance

Shares of NYSE:ELMD opened at $38.58 on Friday. The company has a market capitalization of $319.44 million, a price-to-earnings ratio of 51.44 and a beta of 0.39. The business’s 50-day moving average is $26.51 and its 200-day moving average is $26.80. Electromed, Inc. has a 1 year low of $17.73 and a 1 year high of $39.25.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ELMD. B. Riley Financial upped their price objective on shares of Electromed from $38.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Zacks Research upgraded shares of Electromed from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Finally, Roth Mkm reiterated a “buy” rating and set a $38.00 price objective on shares of Electromed in a report on Wednesday, February 11th. One analyst has rated the stock with a Strong Buy rating and three have issued a Buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $37.50.

Get Our Latest Stock Report on Electromed

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Raymond James Financial Inc. raised its holdings in Electromed by 0.9% during the third quarter. Raymond James Financial Inc. now owns 58,838 shares of the company’s stock worth $1,444,000 after buying an additional 507 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Electromed by 0.4% during the third quarter. Dimensional Fund Advisors LP now owns 190,103 shares of the company’s stock worth $4,667,000 after buying an additional 696 shares during the last quarter. American Century Companies Inc. boosted its stake in Electromed by 3.1% during the 2nd quarter. American Century Companies Inc. now owns 32,031 shares of the company’s stock valued at $704,000 after purchasing an additional 969 shares during the last quarter. Kestra Advisory Services LLC acquired a new position in Electromed during the 4th quarter valued at about $29,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in Electromed during the 4th quarter valued at about $43,000. Institutional investors and hedge funds own 40.82% of the company’s stock.

About Electromed

(Get Free Report)

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.